“The compound SR-17018 is the primary biased agonist on the mu opioid receptor that does not result in tolerance with chronic use,” suggests Stahl, a senior staff members scientist while in the Bohn lab. “It is a appealing feature for potential use during the context of Continual, extreme pain.” https://pauli926vel9.muzwiki.com/user